Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Ocular Therapeutix, Inc. (OCUL) had Profit Margin of -503.86% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$13.46M |
|
$-67.81M |
|
$1.94M |
|
$11.52M |
|
$81.10M |
|
$-67.64M |
|
$-0.17M |
|
$-67.81M |
|
$-67.81M |
|
$-67.81M |
|
$-67.81M |
|
$-67.81M |
|
$-67.81M |
|
$-67.64M |
|
$-66.61M |
|
172.59M |
|
172.59M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$433.38M |
|
$10.46M |
|
$17.96M |
|
$451.33M |
|
$42.93M |
|
$69.91M |
|
$102.49M |
|
$145.42M |
|
$305.92M |
|
$305.92M |
|
$305.92M |
|
172.93M |
|
| Cash Flow Statement Financials | |
$-99.91M |
|
$-3.05M |
|
$101.99M |
|
$393.72M |
|
$392.75M |
|
$-0.97M |
|
$20.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.09 |
|
-- |
|
-- |
|
0.19 |
|
0.23 |
|
85.56% |
|
-502.57% |
|
-502.57% |
|
-- |
|
-503.86% |
|
|
Profit Margin |
-503.86% |
$-102.96M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.64 |
|
0.44 |
|
203.36 |
|
-22.17% |
|
-22.17% |
|
-15.03% |
|
-18.04% |
|
$1.77 |
|
$-0.60 |
|
$-0.58 |
|